COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering
18/04/2018
DAVIS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]
Teladoc to Announce First Quarter 2018 Financial Results
18/04/2018
PURCHASE, NY, April 18, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that it will release first quarter 2018 [...]
Origin Successfully Achieves Phase IIb GENESIS Trial Objectives Ahead of Schedule and Announces Early Termination of Study
18/04/2018
PRINCETON, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase IIb clinical-stage biotechnology company, today announced that the US Food and Drug Administration has approved its request to conclude patient [...]
Alder BioPharmaceuticals® to Present New Phase 3 Migraine Prevention Data for Eptinezumab at the 70th Annual American Academy of Neurology Meeting
18/04/2018
PROMISE 2 Phase 3 study selected for Emerging Science clinical trials plenary presentation session on April 24, 2018 BOTHELL, Wash., April 18, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a [...]
Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
18/04/2018
Agreement with BJC Healthcare Covers Both of the Company’s Thyroid Tests PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully [...]
Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors
18/04/2018
Experienced Life Sciences Executive to Serve as Member of Histogenics Board of Directors WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the [...]
INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device
18/04/2018
PHOENIX, April 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Ceapro Inc. Announces Important Collaboration with Prestigious Montreal Heart Institute
18/04/2018
- Beta-glucan project expected to be Ceapro’s first clinical project led by MHI’s Montreal Health Innovations Coordinating Center (MHICC) - EDMONTON, ALBERTA, April 18, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO [...]
Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018
18/04/2018
NORCROSS, Ga., April 18, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’ [...]
Retrotope Announces Peer-Reviewed Publication of Positive Phase 1b/2a Findings for RT001 in Friedreich’s Ataxia
18/04/2018
Protocol for Pivotal Clinical Trial Has Been Submitted to the US FDA LOS ALTOS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today peer-reviewed publication of positive Phase 1b/2a trial results for [...]
Trayt Unveils Application to Improve Diagnosis, Treatment and Quality of Life for Patients with Autism, ADHD and Neurodevelopmental Disorders
18/04/2018
Big Data and Analytics Platform Measures Efficacy of Interventions and Engages the Entire System of Care REDWOOD CITY, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Trayt , the data analytics company with a platform for [...]
Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
18/04/2018
Grant Expected to Fund Development of OPNT003 to NDA Ready Stage SANTA MONICA, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT ), a specialty pharmaceutical company [...]
CareDx Closes Debt Refinancing
18/04/2018
$15 Million Term Loan with Perceptive Advisors BRISBANE, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and [...]
Fibrocell Announces Review of Strategic Alternatives
18/04/2018
EXTON, Pa., April 18, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
“I Would Choose SkinTE Every Time,” says Patient Treated with PolarityTE’s New Skin Regeneration Product
18/04/2018
SALT LAKE CITY, April 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) today announced continued success with SkinTE during its limited-market release across a variety of conditions, including burns, wounds [...]
83% of People with Alcohol Problems Are Never Encouraged to Seek Treatment
18/04/2018
VANCOUVER, B.C., April 18, 2018 (GLOBE NEWSWIRE) -- With April being Alcohol Awareness Month, studies show 83% of Canadians who drink excessively received no advice or encouragement from family and friends to cut down [...]
AzurRx BioPharma Announces Positive Preclinical Data with AZX1103
18/04/2018
Company is developing AZX1103 for the prevention of nosocomial infections induced by administration of several classes of antibiotics AZX1103 shown to be safe and biologically active in a well-established pre-clinical [...]
Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell
18/04/2018
NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it is in active licensing discussions with several potential partners regarding IV-Cell [...]
Conatus Pharmaceuticals’ IDN-7314 Pan-caspase Inhibitor Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo
18/04/2018
SAN DIEGO, April 18, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]

Pages